Species-specific difference in antimicrobial susceptibility among viridans group streptococci

Annals of Laboratory Medicine

Volumn 35, Issue 2, 2015, Pages 205-211

  Chun, Sejong ^a   Huh, Hee Jae ^a   Lee, Nam Yong ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Microbial; Penicillin; Resistance; Viridans streptococci

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; BODY FLUID; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; STREPTOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; BODY FLUIDS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 84923654266     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2015.35.2.205     Document Type: Article

References (23)

1. Doern CD and Burnham CA. It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations. J Clin Microbiol 2010;48:3829-35.
2. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002;15:613-30.
3. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995;274:1706-13.
4. Tunkel AR and Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002;34:1524-9.
5. Bryskier A. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin Microbiol Infect 2002;8:65-9.
6. Cho EH and Lee NY. Clinical significance of viridans streptococcal bacteremia. Korean J Lab Med 2003;23:246-50.
7. Naiman RA and Barrow JG. Pencillin-resistant bacteria in the mouths and throats of children receiving continuous prophylaxis against rheumatic fever. Ann Intern Med 1963;58:768-72.
8. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988;10:257-85.
9. Farber BF, Eliopoulos GM, Ward JI, Ruoff KL, Syriopoulou V, Moellering RC Jr. Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob Agents Chemother 1983;24:702-5.
10. Quinn JP, DiVincenzo CA, Lucks DA, Luskin RL, Shatzer KL, Lerner SA. Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J Infect Dis 1988;157:764-9.
11. Goldfarb J, Wormser GP, Glaser JH. Meningitis caused by multiply anti-biotic-resistant viridans streptococci. J Pediatr 1984;105:891-5.
12. Diekema DJ, Beach ML, Pfaller MA, Jones RN; SENTRY Participants Group. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin Microbiol Infect 2001;7:152-7.
13. Doern GV, Brueggemann AB, Huynh H, Wingert E. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis 1999;5:757-65.
14. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol 1993;9:635-43.
15. Alcaide F, Liñares J, Pallares R, Carratala J, Benitez MA, Gudiol F, et al. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995;39:2243-7.
16. Han SB, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, et al. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia. Infection 2013;41:914-24.
17. Husain E, Whitehead S, Castell A, Thomas EE, Speert DP. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J 2005; 24:563-6.
18. Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000;31:1126-30.
19. Reinert RR, von Eiff C, Kresken M, Brauers J, Hafner D, Al-Lahham A, et al. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials. J Clin Microbiol 2001;39:1928-31.
20. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82.
21. Jorgensen JH, Barry AL, Traczewski MM, Sahm DF, McElmeel ML, Crawford SA. Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2. J Clin Microbiol 2000;38:2814-8.
22. Kim SJ, Uh Y, Jang IH, Lee KS, Park SD, Yoon KJ. Evaluation of the MicroScan MICroSTREP plus antimicrobial panel for testing β-hemolytic streptococci and viridans group streptococci. Korean J Lab Med 2011; 31:185-90.
23. Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol 2007;45:762-70.